Arrowhead Pharmaceuticals, Inc. ARWR
47.43 USD -10.73 (-18.45%)
Nov 9, 2026, 12:26 PM EST
46.45 Day range 53.63
38.09 52-week range 89.59
- YTD
- -28.56%
- 1 year
- +20.90%
Revenue & Expenses
Latest period ending Sep 30, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| 829.45M | 3.55M | 240.74M | 243.23M | 138.29M | |
| 829.45M | 3.55M | 240.74M | 243.23M | 138.29M | |
| 829.45M | 3.55M | 240.74M | 243.23M | 138.29M | |
| 731.10M | 604.63M | 445.74M | 421.74M | 287.32M | |
| 607.16M | 505.87M | 353.19M | 297.31M | 206.34M | |
| 123.94M | 98.76M | 92.55M | 124.43M | 80.98M | |
| 98.35M | -601.08M | -205.00M | -178.51M | -149.04M | |
| 89.36M | 32.35M | 18.33M | 0 | 0 | |
| 21.42M | -2.77M | 2.78M | 3.79M | 2.00K | |
| -1.63M | -599.49M | -205.28M | -176.06M | -140.85M | |
| -1.63M | -599.49M | -205.28M | -176.06M | -140.85M | |
| -1.63M | -599.49M | -205.28M | -176.06M | -140.85M | |
| 30.11M | -609.69M | -209.28M | -176.49M | -140.85M | |
| 31.75M | -10.20M | -4.00M | -431.00K | 0 | |
| -0.01 | -5.00 | -1.92 | -1.67 | -1.36 | |
| -0.01 | -5.00 | -1.92 | -1.67 | -1.36 | |
| -0.01 | -5.00 | -1.92 | -1.67 | -1.36 | |
| 109.15M | -569.91M | -184.16M | -172.28M | -140.85M | |
| 109.15M | -569.91M | -184.16M | -172.28M | -140.85M | |
| 133.76M | 119.78M | 106.75M | 105.43M | 103.75M | |
| 133.76M | 119.78M | 106.75M | 105.43M | 103.75M |